Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 5491 AL 5505

Alpha-synuclein modulates dopamine neurotransmission

Butler B, Sambo D, Khoshbouei H.

J Chem Neuroanat. 2017 Oct;83-84:41-49. doi: 10.1016/j.jchemneu.2016.06.001. Epub 2016 Jun 19.

Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease

Perez-Lloret S, Rascol O.

CNS Drugs. 2016 Aug;30(8):703-17. doi: 10.1007/s40263-016-0360-5.

Diagnosis of Parkinson’s disease

Suttrup I, Warnecke T.

Med Monatsschr Pharm. 2016 Jul;39(7):282-5.

The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease

Chen S, Chan P, Sun S, Chen H, Zhang B, Le W, Liu C, Peng G, Tang B, Wang L, Cheng Y, Shao M, Liu Z, Wang Z, Chen X, Wang M, Wan X, Shang H, Liu Y, Xu P, Wang J, Feng T, Chen X, Hu X, Xie A, Xiao Q.

Transl Neurodegener. 2016 Jun 30;5:12. doi: 10.1186/s40035-016-0059-z. eCollection 2016.

Human behavioral assessments in current research of Parkinson's disease

Asakawa T, Fang H, Sugiyama K, Nozaki T, Kobayashi S, Hong Z, Suzuki K, Mori N, Yang Y, Hua F, Ding G, Wen G, Namba H, Xia Y.

Neurosci Biobehav Rev. 2016 Sep;68:741-772. doi: 10.1016/j.neubiorev.2016.06.036. Epub 2016 Jun 29.

[Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease]

Marxreiter F, Storch A, Winkler J.

Nervenarzt. 2016 Aug;87(8):805-13. doi: 10.1007/s00115-016-0157-2.

Long-term double-blinded unilateral pedunculopontine area stimulation in Parkinson's disease

Mestre TA, Sidiropoulos C, Hamani C, Poon YY, Lozano AM, Lang AE, Moro E.

Mov Disord. 2016 Oct;31(10):1570-1574. doi: 10.1002/mds.26710.

Sirtuins as modifiers of Parkinson's disease pathology

Tang BL.

J Neurosci Res. 2017 Apr;95(4):930-942. doi: 10.1002/jnr.23806. Epub 2016 Jul 12.

Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease

Hauser RA, Olanow CW, Dzyngel B, Bilbault T, Shill H, Isaacson S, Dubow J, Agro A.

Mov Disord. 2016 Sep;31(9):1366-72. doi: 10.1002/mds.26697. Epub 2016 Jul 19.

Unmasking levodopa resistance in Parkinson's disease

Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR.

Mov Disord. 2016 Nov;31(11):1602-1609. doi: 10.1002/mds.26712. Epub 2016 Jul 19.

New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review

Sánchez-Ferro Á, Elshehabi M, Godinho C, Salkovic D, Hobert MA, Domingos J, van Uem JM, Ferreira JJ, Maetzler W.

Mov Disord. 2016 Sep;31(9):1283-92. doi: 10.1002/mds.26723. Epub 2016 Jul 19.

The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

Martínez-Fernández R, Schmitt E, Martinez-Martin P, Krack P.

Mov Disord. 2016 Aug;31(8):1080-94. doi: 10.1002/mds.26731. Epub 2016 Jul 19.

Free-living monitoring of Parkinson's disease: Lessons from the field

Del Din S, Godfrey A, Mazzà C, Lord S, Rochester L.

Mov Disord. 2016 Sep;31(9):1293-313. doi: 10.1002/mds.26718. Epub 2016 Jul 25.

Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy

Botturi A, Silvani A, Pravettoni G, Paoli RA, Lucchiari C.

Case Rep Neurol. 2016 Jun 6;8(2):115-9. doi: 10.1159/000446643. eCollection 2016 May-Aug.

Use of e-mail for Parkinson's disease consultations: Are answers just a clic away?

Viedma-Guiard E, Agüero P, Crespo-Araico L, Estévez-Fraga C, Sánchez-Díez G, López-Sendón JL, Aviles-Olmos I, García-Ribas G, Palacios Romero ML, Masjuan Vallejo J, Martínez-Castrillo JC, Alonso-Cánovas A.

Neurologia (Engl Ed). 2018 Mar;33(2):107-111. doi: 10.1016/j.nrl.2016.05.020. Epub 2016 Jul 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias